SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 140 filers reported holding SUTRO BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $410,000 | +6.5% | 73,954 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $385,000 | +20.7% | 73,954 | +90.7% | 0.01% | +20.0% |
| Q1 2022 | $319,000 | -92.3% | 38,776 | -82.3% | 0.01% | -92.6% |
| Q3 2021 | $4,147,000 | +1.6% | 219,511 | 0.0% | 0.07% | -10.5% |
| Q2 2021 | $4,081,000 | -17.0% | 219,511 | +1.6% | 0.08% | -30.3% |
| Q1 2021 | $4,916,000 | +24.3% | 215,974 | +18.6% | 0.11% | +3.8% |
| Q4 2020 | $3,955,000 | – | 182,179 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |